These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29360609)

  • 1. A model-based quantification of action control deficits in Parkinson's disease.
    Servant M; van Wouwe N; Wylie SA; Logan GD
    Neuropsychologia; 2018 Mar; 111():26-35. PubMed ID: 29360609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic medication shifts the balance between going and stopping in Parkinson's disease.
    Wylie SA; van Wouwe NC; Godfrey SG; Bissett PG; Logan GD; Kanoff KE; Claassen DO; Neimat JS; van den Wildenberg WPM
    Neuropsychologia; 2018 Jan; 109():262-269. PubMed ID: 29269306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focused stimulation of dorsal subthalamic nucleus improves reactive inhibitory control of action impulses.
    van Wouwe NC; Pallavaram S; Phibbs FT; Martinez-Ramirez D; Neimat JS; Dawant BM; D'Haese PF; Kanoff KE; van den Wildenberg WPM; Okun MS; Wylie SA
    Neuropsychologia; 2017 May; 99():37-47. PubMed ID: 28237741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
    Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
    Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dopamine in action control: Insights from medication effects in Parkinson's disease.
    Ruitenberg MFL; van Wouwe NC; Wylie SA; Abrahamse EL
    Neurosci Biobehav Rev; 2021 Aug; 127():158-170. PubMed ID: 33905788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.
    Duprez J; Houvenaghel JF; Drapier S; Auffret M; Drapier D; Robert G; Vérin M; Sauleau P
    J Neurol; 2018 Mar; 265(3):471-477. PubMed ID: 29285653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic medication improves cognitive control under low cognitive demand in Parkinson's disease.
    Williams IA; Obeso I; Jahanshahi M
    Neuropsychology; 2020 Jul; 34(5):551-559. PubMed ID: 32202819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speed pressure in conflict situations impedes inhibitory action control in Parkinson's disease.
    van Wouwe NC; van den Wildenberg WP; Claassen DO; Kanoff K; Bashore TR; Wylie SA
    Biol Psychol; 2014 Sep; 101():44-60. PubMed ID: 25017503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease.
    Obeso I; Wilkinson L; Casabona E; Bringas ML; Álvarez M; Álvarez L; Pavón N; Rodríguez-Oroz MC; Macías R; Obeso JA; Jahanshahi M
    Exp Brain Res; 2011 Jul; 212(3):371-84. PubMed ID: 21643718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulsive oculomotor action selection in Parkinson's disease.
    Duprez J; Houvenaghel JF; Argaud S; Naudet F; Robert G; Drapier D; Vérin M; Sauleau P
    Neuropsychologia; 2017 Jan; 95():250-258. PubMed ID: 28039058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.
    Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W
    J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease.
    Obeso I; Wilkinson L; Jahanshahi M
    Exp Brain Res; 2011 Sep; 213(4):435-45. PubMed ID: 21796541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Parkinson's disease on the dynamics of on-line and proactive cognitive control during action selection.
    Wylie SA; Ridderinkhof KR; Bashore TR; van den Wildenberg WP
    J Cogn Neurosci; 2010 Sep; 22(9):2058-73. PubMed ID: 19702465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence learning in Parkinson's disease: Focusing on action dynamics and the role of dopaminergic medication.
    Ruitenberg MFL; Duthoo W; Santens P; Seidler RD; Notebaert W; Abrahamse EL
    Neuropsychologia; 2016 Dec; 93(Pt A):30-39. PubMed ID: 27702597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous force measurements reveal no inhibitory control deficits in Parkinson's disease.
    Pickering JS; Leroi I; McBride J; Poliakoff E
    Exp Brain Res; 2020 May; 238(5):1119-1132. PubMed ID: 32222777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intact action segmentation in Parkinson's disease: Hypothesis testing using a novel computational approach.
    Schiffer AM; Nevado-Holgado AJ; Johnen A; Schönberger AR; Fink GR; Schubotz RI
    Neuropsychologia; 2015 Nov; 78():29-40. PubMed ID: 26432343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of promised rewards on conflict resolution in healthy participants and patients with Parkinson's disease.
    Houvenaghel JF; Duprez J; Naudet F; Argaud S; Dondaine T; Drapier S; Robert GH; Drapier D; Vérin M; Sauleau P
    J Neurol Sci; 2016 Aug; 367():38-45. PubMed ID: 27423562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applied strategy in the Iowa Gambling Task: Comparison of individuals with Parkinson's disease to healthy controls.
    Kjær SW; Callesen MB; Larsen L; Borghammer P; Østergaard K; Damholdt MF
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):425-435. PubMed ID: 32283989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.